Trudi P. Visser

799 total citations
20 papers, 599 citations indexed

About

Trudi P. Visser is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Trudi P. Visser has authored 20 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Genetics. Recurrent topics in Trudi P. Visser's work include Hematopoietic Stem Cell Transplantation (8 papers), Virus-based gene therapy research (7 papers) and Mesenchymal stem cell research (5 papers). Trudi P. Visser is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Virus-based gene therapy research (7 papers) and Mesenchymal stem cell research (5 papers). Trudi P. Visser collaborates with scholars based in Netherlands, United Kingdom and Italy. Trudi P. Visser's co-authors include Gerard Wagemaker, Niek P. van Til, Marti F.A. Bierhuizen, Monique M.A. Verstegen, Fatima Aerts‐Kaya, Albertus W. Wognum, Martijn H. Brugman, Edwin F. E. de Haas, Claire Squiban and Floor Weerkamp and has published in prestigious journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Trudi P. Visser

20 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Trudi P. Visser Netherlands	14	285	222	154	147	137	20	599
Gregor Schulz Germany	14	272 1.0×	143 0.6×	365 2.4×	195 1.3×	217 1.6×	19	792
Nobukuni Sawai Japan	15	363 1.3×	197 0.9×	120 0.8×	294 2.0×	227 1.7×	28	713
JN Ihle United States	11	315 1.1×	262 1.2×	334 2.2×	183 1.2×	216 1.6×	16	753
JF DiPersio United States	14	138 0.5×	89 0.4×	219 1.4×	302 2.1×	174 1.3×	24	651
N. Ghanem France	14	265 0.9×	96 0.4×	92 0.6×	292 2.0×	153 1.1×	46	756
Michael Shepard United States	7	238 0.8×	82 0.4×	380 2.5×	259 1.8×	105 0.8×	13	747
CJ Sherr United States	8	336 1.2×	73 0.3×	184 1.2×	304 2.1×	197 1.4×	16	727
Kathryn J. Newhall United States	14	225 0.8×	66 0.3×	288 1.9×	153 1.0×	131 1.0×	25	535
T Nakahata Japan	13	198 0.7×	70 0.3×	106 0.7×	309 2.1×	278 2.0×	30	634
A Faille France	16	275 1.0×	115 0.5×	228 1.5×	166 1.1×	258 1.9×	47	740

Countries citing papers authored by Trudi P. Visser

Since Specialization

Citations

This map shows the geographic impact of Trudi P. Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trudi P. Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trudi P. Visser more than expected).

Fields of papers citing papers by Trudi P. Visser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trudi P. Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trudi P. Visser. The network helps show where Trudi P. Visser may publish in the future.

Co-authorship network of co-authors of Trudi P. Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Trudi P. Visser. A scholar is included among the top collaborators of Trudi P. Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trudi P. Visser. Trudi P. Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Visser, Trudi P., et al.. (2021). CXCR4 expression by mesenchymal stromal cells is lost after use of enzymatic dissociation agents, but preserved by use of non-enzymatic methods. International Journal of Hematology. 113(1). 5–9. 4 indexed citations

2.

Stok, Merel, Helen de Boer, Edwin H. Jacobs, et al.. (2020). Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease. Molecular Therapy — Methods & Clinical Development. 17. 1014–1025. 27 indexed citations

3.

Aerts‐Kaya, Fatima, et al.. (2020). SUL-109 Protects Hematopoietic Stem Cells from Apoptosis Induced by Short-Term Hypothermic Preservation and Maintains Their Engraftment Potential. Biology of Blood and Marrow Transplantation. 26(4). 634–642. 3 indexed citations

4.

Verstegen, Monique M.A., Trudi P. Visser, Dirk Geerts, et al.. (2014). Angiopoietin-Like Protein 3 Promotes Preservation of Stemness during Ex Vivo Expansion of Murine Hematopoietic Stem Cells. PLoS ONE. 9(8). e105642–e105642. 23 indexed citations

5.

Til, Niek P. van, Trudi P. Visser, Julia Hauer, et al.. (2013). Recombination-activating gene 1 (Rag1)–deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome. Journal of Allergy and Clinical Immunology. 133(4). 1116–1123. 46 indexed citations

6.

Aerts‐Kaya, Fatima, Trudi P. Visser, James M. Frincke, et al.. (2012). 5-Androstene-3β,17β-diol Promotes Recovery of Immature Hematopoietic Cells Following Myelosuppressive Radiation and Synergizes With Thrombopoietin. International Journal of Radiation Oncology*Biology*Physics. 84(3). e401–e407. 8 indexed citations

7.

Til, Niek P. van, Helen de Boer, Agnieszka Wabik, et al.. (2012). Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene. Molecular Therapy. 20(10). 1968–1980. 43 indexed citations

8.

Wils, Evert‐Jan, Fatima Aerts‐Kaya, Elwin Rombouts, et al.. (2011). Keratinocyte Growth Factor and Stem Cell Factor to Improve Thymopoiesis after Autologous CD34+ Cell Transplantation in Rhesus Macaques. Biology of Blood and Marrow Transplantation. 18(1). 55–65. 21 indexed citations

9.

Til, Niek P. van, Trudi P. Visser, Martijn H. Brugman, et al.. (2011). Correction of Murine SCID-X1 by Lentiviral Gene Therapy Using a Codon-optimized IL2RG Gene and Minimal Pretransplant Conditioning. Molecular Therapy. 19(10). 1867–1877. 26 indexed citations

10.

Til, Niek P. van, Merel Stok, Fatima Aerts‐Kaya, et al.. (2010). Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype. Blood. 115(26). 5329–5337. 73 indexed citations

11.

Visser, Trudi P., Chris Reading, James M. Frincke, et al.. (2005). HE2100 (5-Androstene-3β,17β-diol) after Cytoreductive Total Body Irradiation of Rhesus Monkeys Promotes the Recovery of Immature CD34+ Bone Marrow Cells, Accelerates Platelet, Granulocyte and Red Cell Reconstitution, and Alleviates Neutropenia and Anemia.. Blood. 106(11). 4203–4203. 4 indexed citations

12.

Weerkamp, Floor, Miranda R.M. Baert, Martijn H. Brugman, et al.. (2005). Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential. Blood. 107(8). 3131–3137. 79 indexed citations

13.

Vardi, Moshe Y., et al.. (2003). New TPO treatment schedules of increased safety and efficacy: pre‐clinical validation of a thrombopoiesis simulation model. British Journal of Haematology. 123(4). 683–691. 31 indexed citations

14.

Mouthon, Marc‐André, Anne Van der Meeren, Marie‐Hélène Gaugler, et al.. (1999). Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. International Journal of Radiation Oncology*Biology*Physics. 43(4). 867–875. 59 indexed citations

15.

Neelis, Karen J., Trudi P. Visser, George Thomas, et al.. (1998). A Single Dose of Thrombopoietin Shortly After Myelosuppressive Total Body Irradiation Prevents Pancytopenia in Mice by Promoting Short-Term Multilineage Spleen-Repopulating Cells at the Transient Expense of Bone Marrow–Repopulating Cells. Blood. 92(5). 1586–1597. 45 indexed citations

16.

Neelis, Karen J., Trudi P. Visser, George Thomas, et al.. (1998). A Single Dose of Thrombopoietin Shortly After Myelosuppressive Total Body Irradiation Prevents Pancytopenia in Mice by Promoting Short-Term Multilineage Spleen-Repopulating Cells at the Transient Expense of Bone Marrow–Repopulating Cells. Blood. 92(5). 1586–1597. 1 indexed citations

17.

Bierhuizen, Marti F.A., et al.. (1997). Green Fluorescent Protein Variants as Markers of Retroviral-Mediated Gene Transfer in Primary Hematopoietic Cells and Cell Lines. Biochemical and Biophysical Research Communications. 234(2). 371–375. 32 indexed citations

18.

Bierhuizen, Marti F.A., et al.. (1997). Enhanced Green Fluorescent Protein as Selectable Marker of Retroviral-Mediated Gene Transfer in Immature Hematopoietic Bone Marrow Cells. Blood. 90(9). 3304–3315. 53 indexed citations

19.

Wagemaker, Gerard, Trudi P. Visser, & D. W. van Bekkum. (1986). CURE OF MURINE THALASSEMIA BY BONE MARROW TRANSPLANTATION WITHOUT ERADICATION OF ENDOGENOUS STEM CELLS. Transplantation. 42(3). 248–251. 17 indexed citations

20.

Visser, Trudi P., et al.. (1982). Alternatives to donor matching for control of graft-versus-host disease. Immunogenetics. 15(1). 79–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact